Clinical Trial Update: Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention [NA]

View source ↗

Summary

Clinical trial update on using Omega-3 fatty acids to prevent breast cancer in ER/PR-negative, with HER2 status variable; the study is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Breast Cancer | NA | Status: ACTIVE_NOT_RECRUITING